UB Paderborn / Katalog / Suche / in CDI

Review of the current role of targeted therapies as maintenance therapies in first and second line treatment of epithelial ovarian cancer; In the light of completed trials

Critical reviews in oncology/hematology, 2016-02, Vol.98, p.180-188

2016

Link zum Volltext

Verfügbarkeit prüfen

Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up

BMC cancer, 2022-11, Vol.22 (1), p.1217-9, Article 1217

2022

Link zum Volltext

Verfügbarkeit prüfen

Demographic and Clinical Features of Patients with Metastatic Breast Cancer: A Retrospective Multicenter Registry Study of the Turkish Oncology Group

Cancers, 2023-03, Vol.15 (6), p.1667

2023

Link zum Volltext

Verfügbarkeit prüfen

Composition of Pancarli Magmatic Ni-Cu±(PGE) Sulfide Deposit in the Cadomian-Avalonian Belt, Eastern Turkey

Journal of earth science (Wuhan, China), 2020-06, Vol.31 (3), p.536-550

2020

Link zum Volltext

Verfügbarkeit prüfen

Three Cases of Breast Metastases from Lung Cancer and Systematic Review of the Literature

European journal of breast health, 2021-04, Vol.17 (2), p.200-205

2021

Link zum Volltext

Verfügbarkeit prüfen

Association between human papillomavirus and endometrial adenocarcinoma

Medical oncology (Northwood, London, England), 2013-09, Vol.30 (3), p.597-597, Article 597

2013

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the association of SNP in carboxylesterase enzyme (CES1) with pharmacokinetic and adverse effects of capecitabine in breast and colorectal cancer patients

Istanbul Journal of Pharmacy, 2019-08, Vol.49 (2), p.64-69

2019

Link zum Volltext

Verfügbarkeit prüfen

Inducible nitric oxide synthase expression in gastric adenocarcinoma: impact on lymphangiogenesis and lymphatic metastasis

Diagnostic pathology, 2013-09, Vol.8 (1), p.151-151, Article 151

2013

Link zum Volltext

Verfügbarkeit prüfen

Metastasis-Induced Acute Pancreatitis Successfully Treated with Chemotherapy and Radiotherapy in a Patient with Small Cell Lung Cancer

Case reports in oncological medicine, 2015-01, Vol.2015, p.304279-5

2015

Link zum Volltext

Verfügbarkeit prüfen

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Journal der Deutschen Dermatologischen Gesellschaft, 2020-01, Vol.18 (1), p.39-41

2020

Link zum Volltext

Verfügbarkeit prüfen

Primary renal carcinoid: Treatment and prognosis

Critical reviews in oncology/hematology, 2013-09, Vol.87 (3), p.256-264

2013

Link zum Volltext

Verfügbarkeit prüfen

A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy

Medicine (Baltimore), 2024-05, Vol.103 (21), p.e37972

2024

Link zum Volltext

Verfügbarkeit prüfen

Pyoderma gangrenosum arising on vinorelbine infusion site with additional histopathological features of syringosquamous metaplasia

Journal der Deutschen Dermatologischen Gesellschaft, 2020-01, Vol.18 (1), p.39-41

2020

Link zum Volltext

Verfügbarkeit prüfen

Entwicklung eines Pyoderma gangraenosum an der Infusionsstelle von Vinorelbin mit zusätzlichen histopathologischen Merkmalen einer syringo‐squamösen Metaplasie

Journal der Deutschen Dermatologischen Gesellschaft, 2020-01, Vol.18 (1), p.39-41

2020

Link zum Volltext

Verfügbarkeit prüfen

Retrospective analysis of ribociclib and letrozole as first-line therapy in patients with hormone receptor (HR) positive metastatic breast cancer (MBC) within a managed access program (MAP) in Turkey

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e13055-e13055

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-11-19: Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P5-P5-11-19

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-11-31: FAVORABLE LOCOREGIONAL CONTROL IN CLINICALLY NODE-NEGATIVE HORMONE-RECEPTOR POSITIVE BREAST CANCER WITH LOW 21-GENE RECURRENCE SCORES: A SINGLE INSTITUTIONAL STUDY WITH 10-YEAR FOLLOW-UP

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P2-P2-11-31

2023

Link zum Volltext

Verfügbarkeit prüfen

GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients

Lung cancer (Amsterdam, Netherlands), 2020-10, Vol.148, p.48-54

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological and prognostic significance of microsatellit instability (MSI) status and PDl-1 expression in Turkish patients with gastric cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e15538-e15538

2019

Link zum Volltext

Verfügbarkeit prüfen

Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?

Journal of cancer research and clinical oncology, 2023-11, Vol.149 (14), p.13271-13277

2023

Link zum Volltext

Verfügbarkeit prüfen

Prognostic role of progesterone receptor (PR) expression by immunohistochemistry (IHC) in relation to Oncotype recurrence scores (RS)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e11589-e11589

2015

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis

Clinical lung cancer, 2015-11, Vol.16 (6), p.e223-e228

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract P3-02-06: Demographic and clinical features of patients with metastatic HER2 positive breast cancer: a retrospective multicenter registry study of the Turkish Oncology Group

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P3-P3-02-06

2023

Link zum Volltext

Verfügbarkeit prüfen

Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study

Future oncology (London, England), 2022-07, Vol.18 (23), p.2573-2582

2022

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Review of the current role of targeted therapies as maintenance therapies in first and second line treatment of epithelial ovarian cancer; In the light of completed trials

Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up

Demographic and Clinical Features of Patients with Metastatic Breast Cancer: A Retrospective Multicenter Registry Study of the Turkish Oncology Group

Composition of Pancarli Magmatic Ni-Cu±(PGE) Sulfide Deposit in the Cadomian-Avalonian Belt, Eastern Turkey

Three Cases of Breast Metastases from Lung Cancer and Systematic Review of the Literature

Association between human papillomavirus and endometrial adenocarcinoma

Evaluation of the association of SNP in carboxylesterase enzyme (CES1) with pharmacokinetic and adverse effects of capecitabine in breast and colorectal cancer patients

Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial

Inducible nitric oxide synthase expression in gastric adenocarcinoma: impact on lymphangiogenesis and lymphatic metastasis

Metastasis-Induced Acute Pancreatitis Successfully Treated with Chemotherapy and Radiotherapy in a Patient with Small Cell Lung Cancer

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Primary renal carcinoid: Treatment and prognosis

A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy

Pyoderma gangrenosum arising on vinorelbine infusion site with additional histopathological features of syringosquamous metaplasia

Entwicklung eines Pyoderma gangraenosum an der Infusionsstelle von Vinorelbin mit zusätzlichen histopathologischen Merkmalen einer syringo‐squamösen Metaplasie

Retrospective analysis of ribociclib and letrozole as first-line therapy in patients with hormone receptor (HR) positive metastatic breast cancer (MBC) within a managed access program (MAP) in Turkey

Abstract P5-11-19: Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey

Abstract P2-11-31: FAVORABLE LOCOREGIONAL CONTROL IN CLINICALLY NODE-NEGATIVE HORMONE-RECEPTOR POSITIVE BREAST CANCER WITH LOW 21-GENE RECURRENCE SCORES: A SINGLE INSTITUTIONAL STUDY WITH 10-YEAR FOLLOW-UP

GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients

Clinicopathological and prognostic significance of microsatellit instability (MSI) status and PDl-1 expression in Turkish patients with gastric cancer

Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?

Prognostic role of progesterone receptor (PR) expression by immunohistochemistry (IHC) in relation to Oncotype recurrence scores (RS)

Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis

Abstract P3-02-06: Demographic and clinical features of patients with metastatic HER2 positive breast cancer: a retrospective multicenter registry study of the Turkish Oncology Group

Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study

Suchergebnisse filtern